|
|
REVIEW ARTICLE |
|
Year : 2021 | Volume
: 12
| Issue : 2 | Page : 64-71 |
|
Severe acute respiratory syndrome-coronavirus-2 viral infection and orofacial clefts: A review on patient care during and after COVID-19 pandemic
Smarika Pravinprakash Jain1, Pavankumar Vibhute1, Chetan Patil1, Vinay Umale1, Balaji Kendre1, Pankaj Akhare2
1 Department of Orthodontics, Yogita Dental College, Ratnagiri, Maharashtra, India 2 Department of Orthodontics, Swargiya Dadasaheb Kalmegh Smruti Dental College, Nagpur, Maharashtra, India
Date of Submission | 13-Oct-2020 |
Date of Decision | 26-May-2021 |
Date of Acceptance | 26-May-2021 |
Date of Web Publication | 04-Aug-2021 |
Correspondence Address: Dr. Smarika Pravinprakash Jain Department of Orthodontics, Yogita Dental College, Khed, Ratnagiri, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijor.ijor_42_20
To summarize the details on severe acute respiratory syndrome-coronavirus-2 (SARS-Cov-2) viral infection and the effects of this infection on care of patients with orofacial clefts and provision of guidelines for orofacial cleft surgeries during Corona virus disease 2019 (COVID-19) by using recent available literature. PubMed and Google Scholar and current reports from major health bodies such as the Centers of Disease Control and Prevention, World Health Organization, National Institutes of Health, and major national associations of cleft lip and palate were searched for information which is relevant from orthodontic care for orofacial cleft point of view. Major priority is given to recent articles and peer-reviewed articles. Narration is done due to limitations in the quality of evidence and rapidly evolving information on the nature of COVID-19. Major relevance to the dental field is human-to human transmission of SARS-CoV-2. People who are infected mostly show mild symptoms, but patients with advanced age or any underlying disease or comorbidity may show severe multiorgan complications. During the COVID-19 pandemic, it is important to maintain social distancing and minimize direct contact. Most clinics and hospitals have determined that multidisciplinary visits, feeding, and speech-language evaluations are largely nonessential and can tolerate a delay. A specific plan with good foundation should be followed for emergency orthodontic care with effective communication and triage.
Keywords: COVID-19, orofacial cleft, pandemic, severe acute respiratory syndrome-coronavirus-2, transmission
How to cite this article: Jain SP, Vibhute P, Patil C, Umale V, Kendre B, Akhare P. Severe acute respiratory syndrome-coronavirus-2 viral infection and orofacial clefts: A review on patient care during and after COVID-19 pandemic. Int J Orthod Rehabil 2021;12:64-71 |
How to cite this URL: Jain SP, Vibhute P, Patil C, Umale V, Kendre B, Akhare P. Severe acute respiratory syndrome-coronavirus-2 viral infection and orofacial clefts: A review on patient care during and after COVID-19 pandemic. Int J Orthod Rehabil [serial online] 2021 [cited 2022 Aug 13];12:64-71. Available from: https://www.orthodrehab.org/text.asp?2021/12/2/64/323096 |
Introduction | |  |
Corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has been designated as a pandemic and Public Health Emergency of International Concern by World Health Organization (WHO). There is a huge amount of risk to the team that is performing the procedures as this infection is transmitted through droplets.
Furthermore, there is increased amount of risk in children and adolescents who are immunocompromised or having any underlying comorbidities and malnutrition.
The knowledge and understanding about this infection is constantly changing and updated through experiences and constant research. The aim of this article review was to provide a comprehensive summary of the implications of SARS-CoV-2 infection and COVID-19 on the care of patients with orofacial clefts and the provision of guidelines for orofacial cleft surgeries during COVID-19, using currently available data and literature.
Materials and Methods | |  |
A wide selection of sources was searched and summarized to ensure that all relevant information regarding the rapidly evolving COVID-19 pandemic and any orthodontic implications for cleft patients were obtained. These sources included peer-reviewed literature publications from electronic databases such as PubMed and Google Scholar using the following search terms: “Coronavirus,” or “COVID-19,” or “SARS-CoV-2,” or “2019-novel coronavirus,” separately combined with “Orofacial cleft,” “cleft lip,” “cleft palate,” “structure,” “incubation,” “latency,” “transmission,” “symptoms,” “dentistry,” “infection control,” “treatment,” and “protocol.” Up-to-date reports and communications from major health bodies such as the Centers for Disease Control and Prevention (CDC), WHO, National Institutes of Health, and major national associations on cleft lip and palate and health professional regulatory bodies were also referenced.
Results | |  |
Due to the rapidly evolving nature of the disease and the need for scientific evidence to be available quickly, most of the studies were descriptive, small investigational studies, narrative reviews, and expert opinions [Table 1]. More recent studies and peer-reviewed studies were preferred when available. As the evidence is still new and limited in quality, a narrative synthesis was undertaken to provide a broad review of key aspects relevant to orthodontists during the current pandemic. | Table 1: Sources of information and literature included in this review article, with levels of evidence*
Click here to view |
Discussion | |  |
Structure of the virus
SARS-CoV-2 is a single-stranded RNA virus. Electron microscopy revealed the coronavirus-specific morphology of SARS-CoV-2 with virus particle sizes ranging from 70 nm to 90 nm.[1],[2],[3] A surface viral protein named spike glycoprotein is present on virus which interacts with cell surface having angiotensin-converting enzyme 2 (ACE2) receptor. The viral membrane glycoprotein (M) and envelope (E) of SARS-CoV-2 are embedded in host membrane-derived lipid bilayer encapsulating the helical nucleocapsid comprising viral RNA [Figure 1].[4],[5]
Pathophysiology
The genome of SARS-CoV-2 is similar to other coronaviruses that comprise of ten open reading frames (ORFs). The first ORFs (ORF1a/b), about two-thirds of viral RNA, are translated into two large polyproteins pp1a and pp1ab, which processed into nonstructural proteins (nsp1nsp16).[20],[21] The genome of SARS-CoV-2 encodes for four structural proteins similar to other coronaviruses. These proteins are S (spike), E (envelope), M (membrane), and N (nucleocapsid) protein which are required to make complete virus particles [Figure 2].
S protein is responsible for the attachment and entry of SARS-CoV-2 to the host target cell receptor, probably ACE2 mainly expressed on Alveolar epithelial cell type II (AECII) cells, including extrapulmonary tissues such as heart, kidney, endothelium, and intestine [Figure 3].[22] | Figure 3: Binding of severe acute respiratory syndrome-coronavirus-2 to cell membrane
Click here to view |
Symptoms and progression of disease
As we have seen children and adolescents have lower death rates still they can be a potential transmitter of infection. Children infected with coronavirus often present with fever, cough, and breathing difficulties [Figure 4]. | Figure 4: Severe acute respiratory syndrome-coronavirus-2 has been shown to exhibit novel glycosylation sites in the spike glycoprotein of 2019-novel coronavirus, suggesting that the virus may utilize different glycosylation sites to interact with its receptors. Studies have demonstrated that severe acute respiratory syndrome-coronavirus-2 spike protein has higher af?nity to the angiotensin-converting enzyme 2 receptor as compared with severe acute respiratory syndrome[23]
Click here to view |
Many children also report vomiting, diarrhea and a fore mentioned symptom. Children born from infected mothers have higher risk of contracting the infection from the mother.[6] There is also very close resemblance of the symptoms with coronavirus and viral pneumonia. It has been reported that children often have milder symptoms than adults and the elderly.[7],[8],[9],[10]
Transmission
A report mentions that even an apparently healthy infant had heavy viral load which indicates that children can even transmit infection without manifesting the illness [Figure 5].[11],[12],[13],[14],[15],[16],[17],[18],[19]
Phases of severe acute respiratory syndrome-coronavirus-2 infections
Based on current epidemiological investigation, the incubation period is 1–14 days, mostly 4–7 days. And the COVID-19 is contagious during the latency period [Figure 6].[23],[24] | Figure 6: Six phases of severe acute respiratory syndrome-coronavirus-2 infections[24]
Click here to view |
COVID-19 and orofacial cleft
Many syndromes have cleft as a part of it which could increase the risk of infection. However, an unrepaired cleft without syndrome doesn't make someone more likely to catch the virus. The two most common syndromes where a cleft (usually cleft palate) is a symptom are pierre robin sequence and sticklers syndrome.
Delaying cleft lip and/or palate repair surgery
Careful priority should be given to the backlog surgeries of cleft which was scheduled [Table 2]. | Table 2: Recommended protocol for Cleft lip and palate patient care during and after COVID-19 pandemic
Click here to view |
Speech is mainly affected by cleft palate repair which makes it more time-sensitive. However, research is ongoing to work out when the best time to operate is, as there's no clear evidence that 6 months is better than 12 months.
For alveolar bone graft surgery, there is a reasonably long “window of opportunity” during which this can be performed, so the most important thing at this time is keeping up the care of any orthodontic appliances.
Most orthodontic appliances can be left as they are for some months without issues as long as the usual aftercare instructions are followed.
- Maintaining excellent oral hygiene: Brush three times a day with a standard toothbrush, followed by an interdental brush. Use a fluoride mouthwash once a day
- Low sugar diet: Where possible, avoid all snacking on sugars and drinks with added sugar. Avoid fizzy drinks in particular
- Avoid hard or sticky food: that could break the brace wire or brackets off a tooth.
Conclusions | |  |
- Despite low mortality and low infection rate among children and adolescents, they play a crucial role in the spread of infection in this ongoing pandemic of coronavirus disease
- Adequate prevention measures, early identification, and isolation will be helpful in altering the course of this pandemic
- Telehealth or phone conversations with parents may be sufficient
- It is also imperative that care teams proactively establish a re-entry plan and prioritize patients for future evaluation and treatment
- Guidelines and practice advisories issued by federal, state/provincial, and local health and regulatory authorities should be followed[44].
Acknowledgment
The author would like to thank Dr. Pavankumar Vibhute for their guidance and support.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Park WB, Kwon NJ, Choi SJ, Kang CK, Choe PG, Kim JY, et al. Virus isolation from the first patient with SARS-CoV-2 in Korea. J Korean Med Sci 2020;35:e84. |
2. | Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease 2020;31:13-21. |
3. | Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. |
4. | Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020;367:1444-8. |
5. | Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science 2020;368:409-12. |
6. | Yang P, Liu P, Li D, Zhao D. Corona virus disease 2019, a growing threat to children? J Infect 2020;80:671-93. |
7. | Cruz AT, Zeichner SL. COVID 19 in children: Initial characterization of the pediatric disease. Pediatrics 2020;145:1-6. |
8. | Dong Y, Mo X, Hu Y, Xin Qi, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China.J Emerg Med 2020;58:712-3. |
9. | Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020;16:240-6. |
10. | Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol 2020;55:1169-74. |
11. | Kam KQ, Yung CF, Cui L, Tzer Pin Lin R, Mak TM, Maiwald M, et al. A well infant with coronavirus disease 2019 with high viral load. Clin Infect Dis 2020;71:847-9. |
12. | Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020;158:1518-9. |
13. | |
14. | Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, et al. Anesthetic management of patients with COVID 19 infections during emergency procedures. J Cardiothorac Vasc Anesth 2020;34:1125-31. |
15. | Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev 2013;77:144-56. |
16. | Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020;395:e39. |
17. | Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13. |
18. | Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382:970-1. |
19. | To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent detection of 2019 novel coronavirus in Saliva. Clin Infect Dis 2020;71:841-3. |
20. | Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74. |
21. | Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020;9:221-36. |
22. | Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-An update on the status. Mil Med Res 2020;7:11. |
23. | Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS CoV 2 spike glycoprotein. Cell 2020;16;181:281-292. |
24. | Suri S, Vandersluis YR, Kochhar AS, Bhasin R, Abdallah MN. Clinical orthodontic management during the COVID-19 pandemic. Angle Orthod 2020;90:473-84. |
25. | Wang Y, Kang H, Liu X, Tong Z. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol 2020;92:538-9. |
26. | Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol 2020;92:1518-1524. |
27. | Zhou S, Wang Y, Zhu T, Xia L. CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J Roentgenol 2020;214:1287-94. |
28. | Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020;295:202-7. |
29. | Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 2020;172:577-82. |
30. | Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA 2020;323:1502-3. |
31. | Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020;133:1039-43. |
32. | Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife 2020;9:e55570. |
33. | |
34. | |
35. | Cleft Lip and Palate Association (CLAPA): Cleft and COVID-19. Available from: https://www.clapa.com/covid. [Last accessed on 2020 Jul 15]. |
36. | van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564-7. |
37. | Zhou P, Yang XL, Wang XG, Ben Hu, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-73. |
38. | Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207. |
39. | Wang Y, Zhou CC, Shu R, Zou J. Oral health management of children during the epidemic period of coronavirus disease 2019. Sichuan Da Xue Xue Bao Yi Xue Ban 2020;51:151-4. |
40. | Sabino-Silva R, Jardim ACG, Siqueira WL. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig 2020;24:1619-21. |
41. | |
42. | |
43. | Ti LK, Ang LS, Foong TW, Ng BS. What we do when a COVID-19 patient needs an operation: Operating room preparation and guidance. Can J Anaesth 2020;67:756-8. |
44. | Kim HJ, Ko JS, Kim TY. Recommendations for anesthesia in patients suspected of COVID-19 Coronavirus infection. Korean J Anesthesiol 2020;73:89-91. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
[Table 1], [Table 2]
|